What is the first-line treatment for acute otitis media (AOM) in pediatric (peds) patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Acute Otitis Media in Pediatric Patients

The first-line treatment for acute otitis media (AOM) in pediatric patients is amoxicillin at a dosage of 80-90 mg/kg/day. 1, 2

Diagnosis Criteria

  • AOM is diagnosed in children with moderate to severe bulging of the tympanic membrane or new-onset otorrhea not due to acute otitis externa 2
  • AOM can also be diagnosed with mild bulging of the tympanic membrane and recent onset of ear pain (less than 48 hours) or intense erythema of the tympanic membrane 2

Treatment Algorithm Based on Age and Severity

Children 6-23 months:

  • Severe AOM or bilateral AOM (regardless of severity): Immediate antibiotic therapy 2
  • Non-severe unilateral AOM: Either immediate antibiotics or observation with close follow-up based on joint decision-making with parents/caregivers 2

Children ≥24 months:

  • Severe AOM: Immediate antibiotic therapy 2
  • Non-severe AOM (unilateral or bilateral): Either immediate antibiotics or observation with close follow-up 2

Antibiotic Selection and Dosing

  • First-line therapy: Amoxicillin 80-90 mg/kg/day divided into 2-3 doses 3, 1, 2

    • Duration: 10 days for children <2 years; 5-7 days for children ≥2 years with mild/moderate symptoms 3, 4
  • Second-line therapy (treatment failure or high-risk situations): Amoxicillin-clavulanate 3, 2

    • Indications for second-line therapy:
      • Amoxicillin treatment in the past 30 days
      • Concurrent purulent conjunctivitis
      • Recurrent AOM unresponsive to amoxicillin 2
  • For penicillin allergy: 1, 4

    • Non-type I hypersensitivity: Cefdinir, cefpodoxime, or cefuroxime
    • Type I hypersensitivity: Azithromycin or clarithromycin

Pain Management

  • Pain control should be addressed immediately regardless of whether antibiotics are prescribed 1, 2
  • Appropriate analgesics include acetaminophen or ibuprofen at age-appropriate doses 4
  • Continue analgesics as long as needed to control pain 2

Follow-up and Treatment Failure

  • If symptoms worsen or fail to improve within 48-72 hours, reassess to confirm diagnosis 3, 2
  • For treatment failure, switch to a second-line agent such as amoxicillin-clavulanate 1, 2
  • Consider tympanocentesis for bacteriologic diagnosis in patients who fail multiple courses of antibiotics 3

Important Considerations

  • The WHO Expert Committee strongly recommends amoxicillin as first choice and amoxicillin-clavulanic acid as second choice for AOM 3
  • Observation without antibiotics is appropriate in select cases, with approximately two-thirds of children improving without antibiotics 3
  • Persistent middle ear effusion after AOM resolution is common (60-70% at 2 weeks, 40% at 1 month) and does not require additional antibiotics 3
  • Completing the full course of antibiotics is essential, even if symptoms improve before completion 1

Prevention Strategies

  • Ensure up-to-date immunization with pneumococcal conjugate vaccines 4, 2
  • Consider annual influenza vaccination 4
  • Encourage breastfeeding for at least six months 2
  • Reduce or eliminate pacifier use after six months of age 2

References

Guideline

Treatment for Acute Otitis Media in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Otitis Media Management in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.